Stock BGD BIOGENED S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Biogened S.A.

Equities

BGD

PLBIOGN00018

Pharmaceuticals

End-of-day quote Warsaw S.E.
Other stock markets
 03:30:00 17/07/2024 am IST 		5-day change 1st Jan Change
19.9 PLN -2.45% Intraday chart for Biogened S.A. -7.01% +10.56%
15/05 Biogened S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
14/02 Biogened S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 20.39 17.19 20.88 21.12 31.2 44.21
Enterprise Value (EV) 1 41.81 38.06 35.42 34.86 50.72 59.16
P/E ratio 17.9 x 13.5 x 16.8 x 10.8 x 9.23 x 8.67 x
Yield - - 2.35% - 3.15% 2.78%
Capitalization / Revenue 0.51 x 0.37 x 0.43 x 0.32 x 0.39 x 0.46 x
EV / Revenue 1.04 x 0.82 x 0.73 x 0.53 x 0.64 x 0.62 x
EV / EBITDA 5.83 x 5.01 x 5.24 x 4.72 x 4.5 x 5.06 x
EV / FCF -54.4 x 214 x 2.38 x 4.46 x -16.6 x 9.22 x
FCF Yield -1.84% 0.47% 41.9% 22.4% -6.04% 10.8%
Price to Book 0.39 x 0.32 x 0.38 x 0.71 x 0.96 x 1.2 x
Nbr of stocks (in thousands) 2,456 2,456 2,456 2,456 2,456 2,456
Reference price 2 8.300 7.000 8.500 8.600 12.70 18.00
Announcement Date 14/05/19 14/05/20 13/05/21 30/05/22 30/05/23 29/05/24
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 40.24 46.63 48.33 65.32 79.62 95.56
EBITDA 1 7.171 7.604 6.761 7.388 11.28 11.69
EBIT 1 3.393 3.348 2.359 4.589 8.376 8.164
Operating Margin 8.43% 7.18% 4.88% 7.03% 10.52% 8.54%
Earnings before Tax (EBT) 1 1.986 1.927 2.176 4.329 6.39 6.889
Net income 1 1.137 1.272 1.242 1.961 3.381 5.097
Net margin 2.83% 2.73% 2.57% 3% 4.25% 5.33%
EPS 2 0.4629 0.5177 0.5054 0.7982 1.377 2.075
Free Cash Flow 1 -0.7691 0.1781 14.86 7.82 -3.065 6.417
FCF margin -1.91% 0.38% 30.74% 11.97% -3.85% 6.72%
FCF Conversion (EBITDA) - 2.34% 219.74% 105.84% - 54.92%
FCF Conversion (Net income) - 14.01% 1,196.6% 398.84% - 125.91%
Dividend per Share - - 0.2000 - 0.4000 0.5000
Announcement Date 14/05/19 14/05/20 13/05/21 30/05/22 30/05/23 29/05/24
1PLN in Million2PLN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 21.4 20.9 14.5 13.7 19.5 14.9
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.987 x 2.744 x 2.151 x 1.859 x 1.73 x 1.279 x
Free Cash Flow 1 -0.77 0.18 14.9 7.82 -3.06 6.42
ROE (net income / shareholders' equity) 2.18% 2.38% 2.28% 4.63% 10.8% 14.7%
ROA (Net income/ Total Assets) 2.62% 2.5% 1.75% 3.97% 7.91% 6.81%
Assets 1 43.41 50.83 70.77 49.36 42.73 74.82
Book Value Per Share 2 21.50 22.00 22.30 12.20 13.30 14.90
Cash Flow per Share 2 0.4300 0.4900 1.040 2.020 1.410 3.060
Capex 1 4.47 3.67 1.83 1.57 9.36 7.15
Capex / Sales 11.1% 7.87% 3.79% 2.4% 11.76% 7.49%
Announcement Date 14/05/19 14/05/20 13/05/21 30/05/22 30/05/23 29/05/24
1PLN in Million2PLN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
BIOGENED S.A. Stock Biogened S.A.
+10.56% 12.44M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+26.58% 45.33B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+38.49% 25.36B
SANDOZ GROUP AG Stock Sandoz Group AG
+27.75% 16.7B
CIPLA LIMITED Stock Cipla Limited
+20.89% 14.59B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+72.03% 14.26B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-10.35% 6.67B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+13.07% 5.62B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BGD Stock
  4. Financials Biogened S.A.